STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer’s disease and pain, toda…
PALO ALTO, CA / ACCESSWIRE / January 31, 2024 / Bioz, Inc., a leading AI software company based in Silicon Valley, is excited to announce its partnership with Larodan, a prominent manufacturer of research grade lipids. Thousands of Larodan’s products h…
LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) issues the following trading update for the period 1 October 2023 to 31 December 2023. This update is released ahead of the Group’s audited full year results on 27 Ma…
Ondine Biomedical demonstrated that photodisinfection does not harm the nasal microbiomeVANCOUVER, BC / ACCESSWIRE / January 31, 2024 / Research presented by Canadian life sciences company, Ondine Biomedical Inc. (“Ondine Biomedical”, “O…
Block Admission ReturnMANCHESTER, UK / ACCESSWIRE / January 31, 2024 / THE PEBBLE GROUP PLCName of applicant:The Pebble Group PlcName of scheme:The Sharesave PlansPeriod of return:From:31 July 2023To:31 January 2024Balance of unallotted securities unde…
LONDON, UK / ACCESSWIRE / January 31, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that it has entered into an amendment and extension of its $150 million revolving credit facility agreement with its existing syndicate of Scotiabank, CIBC …
LONDON, ENGLAND / ACCESSWIRE / January 31, 2024 / Argo Blockchain plc (“Argo” or “the Company”), a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), announces that it has issued 154,475 new ordinary shares of £0.001 eac…
MagnetOs ™ Granules becomes the third product in the MagnetOs portfolio to receive FDA clearance to market for interbody useKuros continues expansion of the MagnetOs franchise with launch of MagnetOs Granules and MagnetOs Putty in New Zealand via an ex…